GlassScriptPhysician profile
Matthew Gubbels
NPI 1598384083
$2,815.78
in general payments reported to CMS, 2019-2025
7 companies · $2,628 in 2025
The $2,628 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.50 · 2024: $174 · 2025: $2,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,969 · Grant: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,969.28 |
| Grant | $833.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,019.59 | 2025 | Osteocool Rf Ablation System |
| Boston Scientific Corporation | $595.43 | 2024-2025 | General - Embolics, Embold Fibered, General - Vascular Intervention |
| Penumbra, INC. | $425.48 | 2021-2025 | Indigo System, Ruby Coil, Penumbra System |
| Balt USA, LLC | $382.74 | 2025 | Prestige Coil System, Revere Hybrid Access Catheter |
| Inari Medical, INC. | $198.71 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $103.19 | 2025 | Esprit |
| Trisalus Life Sciences, INC. | $90.64 | 2024-2025 | Trinav Infusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Gubbels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.